Nature Communications,
Год журнала:
2022,
Номер
13(1)
Опубликована: Июль 13, 2022
Abstract
Leishmania
are
unicellular
parasites
that
cause
human
and
animal
diseases.
Like
other
kinetoplastids,
they
possess
large
transcriptional
start
regions
(TSRs)
which
defined
by
histone
variants
lysine
acetylation.
Cellular
interpretation
of
these
chromatin
marks
is
not
well
understood.
Eight
bromodomain
factors,
the
reader
modules
for
acetyl-lysine,
found
across
genomes.
Using
L.
mexicana
,
Cas9-driven
gene
deletions
indicate
BDF1–5
essential
promastigotes.
Dimerisable,
split
Cre
recombinase
(DiCre)-inducible
deletion
BDF5
show
it
both
promastigotes
murine
infection.
ChIP-seq
identifies
as
enriched
at
TSRs.
XL-BioID
proximity
proteomics
shows
landscape
BDFs,
HAT2,
proteins
involved
in
activity,
RNA
processing;
revealing
a
Conserved
Regulators
Kinetoplastid
Transcription
(CRKT)
Complex.
Inducible
causes
global
reduction
polymerase
II
transcription.
Our
results
requirement
to
interpret
acetylation
through
bromodomain-enriched
CRKT
complex
normal
expression
cellular
viability.
Nature Reviews Microbiology,
Год журнала:
2022,
Номер
21(1), С. 35 - 50
Опубликована: Авг. 22, 2022
Leishmaniasis
(visceral
and
cutaneous),
Chagas
disease
human
African
trypanosomiasis
cause
substantial
death
morbidity,
particularly
in
low-
middle-income
countries.
Although
the
situation
has
improved
for
trypanosomiasis,
there
remains
an
urgent
need
new
medicines
to
treat
leishmaniasis
disease;
clinical
development
pipeline
is
sparse
disease.
In
this
Review,
we
describe
recent
advances
our
understanding
of
biology
causative
pathogens,
from
drug
discovery
perspective,
explore
progress
that
been
made
candidates
identification
promising
molecular
targets.
We
also
challenges
developing
discuss
potential
solutions
overcome
such
hurdles.
Gilbert
colleagues
kinetoplastid
diseases
how
parasite
affects
process
International Journal for Parasitology Drugs and Drug Resistance,
Год журнала:
2018,
Номер
8(3), С. 430 - 439
Опубликована: Сен. 28, 2018
Tritryps
diseases
are
devastating
parasitic
neglected
infections
caused
by
Leishmania
spp.,
Trypanosoma
cruzi
and
brucei
subspecies.
Together,
these
parasites
affect
more
than
30
million
people
worldwide
cause
high
mortality
morbidity.
Leishmaniasis
comprises
a
complex
group
of
with
clinical
manifestation
ranging
from
cutaneous
lesions
to
systemic
visceral
damage.
Antimonials,
the
first-choice
drugs
used
treat
leishmaniasis,
lead
toxicity
carry
significant
contraindications
limiting
its
use.
Drug-resistant
parasite
strains
also
matter
for
increasing
concern,
especially
in
areas
very
limited
resources.
The
current
scenario
calls
novel
and/or
improvement
existing
therapeutics
as
key
research
priorities
field.
Although
several
studies
have
shown
advances
drug
discovery
towards
leishmaniasis
recent
years,
knowledge
gaps
pipelines
still
need
be
addressed.
In
this
review
we
discuss
not
only
scientific
non-scientific
bottlenecks
development,
but
central
role
public-private
partnerships
successful
campaign
treatment
options
against
disease.
Nature Communications,
Год журнала:
2021,
Номер
12(1)
Опубликована: Фев. 23, 2021
Abstract
Differentiation
between
distinct
stages
is
fundamental
for
the
life
cycle
of
intracellular
protozoan
parasites
and
transmission
hosts,
requiring
stringent
spatial
temporal
regulation.
Here,
we
apply
kinome-wide
gene
deletion
tagging
in
Leishmania
mexicana
promastigotes
to
define
protein
kinases
with
transition
roles.
Whilst
162
are
dispensable,
44
kinase
genes
refractory
likely
core
required
parasite
replication.
Phenotyping
pooled
mutants
using
bar-seq
projection
pursuit
clustering
reveal
functional
phenotypic
groups
involved
differentiation
from
metacyclic
promastigote
amastigote,
growth
survival
macrophages
mice,
colonisation
sand
fly
motility.
This
unbiased
interrogation
function
allows
targeted
investigation
organelle-associated
signalling
pathways
successful
parasitism.
Drug Development Research,
Год журнала:
2020,
Номер
83(2), С. 225 - 252
Опубликована: Апрель 6, 2020
Abstract
Human
trypanosomiasis
and
leishmaniasis
are
vector‐borne
neglected
tropical
diseases
caused
by
infection
with
the
protozoan
parasites
Trypanosoma
spp.
Leishmania
spp.,
respectively.
Once
restricted
to
endemic
areas,
these
now
distributed
worldwide
due
human
migration,
climate
change,
anthropogenic
disturbance,
causing
significant
health
economic
burden
globally.
The
current
chemotherapy
used
treat
has
limited
efficacy,
drug
resistance
is
spreading.
Hence,
new
drugs
urgently
needed.
Phenotypic
compound
screenings
have
prevailed
as
leading
method
discover
candidates
against
diseases.
However,
publication
of
complete
genome
sequences
multiple
strains,
advances
in
application
CRISPR/Cas9
technology,
vivo
bioluminescence‐based
imaging
set
stage
for
advancing
target‐based
discovery.
This
review
analyses
limitations
narrow
pool
available
presently
treating
It
describes
drug‐based
clinical
trials
highlighting
most
promising
leads.
Furthermore,
presents
a
focused
discussion
on
important
biological
pharmacological
challenges
that
discovery
programs
must
overcome
advance
candidates.
Finally,
it
examines
advantages
modern
research
tools
designed
identify
validate
essential
genes
targets,
including
genomic
editing
applications
imaging.
Proceedings of the National Academy of Sciences,
Год журнала:
2025,
Номер
122(8)
Опубликована: Фев. 18, 2025
While
advances
in
genome
editing
technologies
have
simplified
gene
disruption
many
organisms,
the
study
of
essential
genes
requires
development
conditional
or
knockdown
systems
that
are
not
available
most
organisms.
Such
is
case
for
Trypanosoma
cruzi,
a
parasite
causes
Chagas
disease,
severely
neglected
tropical
disease
endemic
to
Latin
America
often
fatal.
Our
knowledge
identity
and
their
functions
T.
cruzi
has
been
constrained
by
historical
challenges
very
basic
genetic
manipulation
absence
RNA
interference
machinery.
Here,
we
describe
use
self-cleaving
sequences
conditionally
regulate
expression
cruzi.
Using
these
tools,
identified
roles
Polo-like
Aurora
kinases
cell
division,
mirroring
brucei.
Importantly,
demonstrate
intracellular
amastigotes,
disease-causing
stage
its
human
host.
This
system
enables
efficient
scalable
functional
characterization
provides
framework
other
nonmodel
Nature Communications,
Год журнала:
2025,
Номер
16(1)
Опубликована: Янв. 2, 2025
Abstract
For
the
protozoan
parasite
Leishmania
,
completion
of
its
life
cycle
requires
sequential
adaptation
cellular
physiology
and
nutrient
scavenging
mechanisms
to
different
environments
a
sand
fly
alimentary
tract
acidic
mammalian
host
cell
phagolysosome.
Transmembrane
transporters
are
gatekeepers
intracellular
environments,
controlling
flux
solutes
ions
across
membranes.
To
discover
which
vital
for
survival
as
amastigote
forms,
we
carried
out
systematic
loss-of-function
screen
L.
mexicana
transportome.
A
total
312
protein
components
small
molecule
carriers,
ion
channels
pumps
were
identified
targeted
in
CRISPR-Cas9
gene
deletion
promastigote
form,
yielding
188
viable
null
mutants.
Forty
transporter
deletions
caused
significant
loss
fitness
macrophage
mouse
infections.
striking
example
is
Vacuolar
H
+
ATPase
(V-ATPase),
which,
unexpectedly,
was
dispensable
growth
vitro
but
essential
disease-causing
amastigotes.
PLoS Pathogens,
Год журнала:
2020,
Номер
16(6), С. e1008455 - e1008455
Опубликована: Июнь 16, 2020
The
parasitic
protozoan
Leishmania
requires
proteasomal,
autophagic
and
lysosomal
proteolytic
pathways
to
enact
the
extensive
cellular
remodelling
that
occurs
during
its
life
cycle.
proteasome
is
essential
for
parasite
proliferation,
yet
little
known
about
requirement
ubiquitination/deubiquitination
processes
in
growth
differentiation.
Activity-based
protein
profiling
of
L.
mexicana
C12,
C19
C65
deubiquitinating
cysteine
peptidases
(DUBs)
revealed
DUB
activity
remains
relatively
constant
differentiation
procyclic
promastigote
amastigote.
However,
when
cycle
phenotyping
(bar-seq)
was
performed
on
a
pool
including
15
barcoded
null
mutants
created
promastigotes
using
CRISPR-Cas9,
significant
loss
fitness
observed
intracellular
infection.
DUBs
4,
7,
13
are
required
successful
transformation
from
metacyclic
amastigote
3,
5,
6,
8,
10,
11
14
normal
proliferation
mice.
1,
2,
12
16
viability
role
DUB2
establishing
infection
demonstrated
DiCre
inducible
gene
deletion
vitro
vivo.
found
nucleus
interacts
with
nuclear
proteins
associated
transcription/chromatin
dynamics,
mRNA
splicing
capping.
has
broad
linkage
specificity,
cleaving
all
di-ubiquitin
chains
except
Lys27
Met1.
Our
study
demonstrates
crucial
play
survival
amastigotes
exquisitely
sensitive
disruption
ubiquitination
homeostasis.
CRISPR/Cas9
gene
editing
has
revolutionised
loss-of-function
experiments
in
Leishmania
,
the
causative
agent
of
leishmaniasis.
As
lack
a
functional
non-homologous
DNA
end
joining
pathway
however,
obtaining
null
mutants
typically
requires
additional
donor
DNA,
selection
drug
resistance-associated
edits
or
time-consuming
isolation
clones.
Genome-wide
screens
across
different
conditions
and
multiple
species
are
therefore
unfeasible
at
present.
Here,
we
report
cytosine
base
editor
(CBE)
toolbox
that
overcomes
these
limitations.
We
employed
CBEs
to
introduce
STOP
codons
by
converting
into
thymine
created
http://www.leishbaseedit.net/
for
CBE
primer
design
kinetoplastids.
Through
reporter
assays
targeting
single-
multi-copy
genes
L.
mexicana
major
donovani
infantum
demonstrate
how
this
tool
can
efficiently
generate
expressing
just
one
single-guide
RNA,
reaching
up
100%
rate
non-clonal
populations.
then
generated
-optimised
successfully
targeted
an
essential
plasmid
library
delivered
screen
.
Since
our
method
does
not
require
double-strand
breaks,
homologous
recombination,
clones,
believe
enables
first
time
genetic
via
delivery
libraries.